LobbyingUnited Mitochondrial Disease Foundation lobbying by quarter
United Mitochondrial Disease Foundation's latest lobbying report covers Q2 2026, at $20K. The four quarters Q3 2025–Q2 2026 total $80K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.
United Mitochondrial Disease Foundation
- Latest quarter
- $20K
- Q2 2026 · 1 reports
- Last 12 months
- $80K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $20K | 1 |
| Q1 2023 | $20K | 1 |
| Q2 2023 | $20K | 1 |
| Q3 2023 | $20K | 1 |
| Q4 2023 | $20K | 1 |
| Q1 2024 | $20K | 1 |
| Q2 2024 | $20K | 1 |
| Q3 2024 | $20K | 1 |
| Q4 2024 | $20K | 1 |
| Q1 2025 | $20K | 1 |
| Q2 2025 | $20K | 1 |
| Q3 2025 | $20K | 1 |
| Q4 2025 | $20K | 1 |
| Q1 2026 | $20K | 1 |
| Q2 2026 | $20K | 1 |
Policy issues the reports name
- Budget and appropriations15 reports
- Health issues15 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| Holland & Knight | $300K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JORDAN BROSSI | Staff Asst., Leg. Cor., Sen. Tammy Baldwin; Leg. Cor., Sen. Joe Manchin; LA, Rep. Susie Lee; Health LA & Health Pol. Adv., Rep. Anna Eshoo, | Q1 2026 |
| SARAH STARLING CROSSAN | Staff Assistant, Sen. Lamar Alexander; Professional Staff, Health, Education, Labor, and Pensions (HELP) Cmte.; Legislative Correspondent, Sen. Lamar Alexander | Q1 2026 |
| ABIGAIL HEMENWAY | Staff Assistant, Senate Committee on Energy & Natural Resources; Staff Assistant, Legislative Correspondent, Legislative Aide, Sen. Lisa Murkowski | Q2 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/17for Q2 | Holland & Knight | $20K |
| 04/16for Q1 | Holland & Knight | $20K |
| 01/20for Q4 2025 | Holland & Knight | $20K |
| 25/10/18for Q3 2025 | Holland & Knight | $20K |
| 25/07/11for Q2 2025 | Holland & Knight | $20K |
| 25/04/13for Q1 2025 | Holland & Knight | $20K |
| 25/01/20for Q4 2024 | Holland & Knight | $20K |
| 24/10/15for Q3 2024 | Holland & Knight | $20K |
| 24/07/08for Q2 2024 | Holland & Knight | $20K |
| 24/04/19for Q1 2024 | Holland & Knight | $20K |
| 24/01/20for Q4 2023 | Holland & Knight | $20K |
| 23/10/15for Q3 2023 | Holland & Knight | $20K |
| 23/07/15for Q2 2023 | Holland & Knight | $20K |
| 23/04/14for Q1 2023 | Holland & Knight | $20K |
| 23/01/18for Q4 2022 | Holland & Knight | $20K |